幽门螺杆菌根除和高密度脂蛋白对新发胃癌风险的影响
这项大型回顾性队列研究纳入2003至2011年接受内镜和幽门螺杆菌检测、随访至2013年的10328名健康受试者,中位随访5.5年期间检出31例胃癌;调整分析显示幽门螺杆菌成功根除降低新发胃癌风险(HR 0.29;95%CI 0.10-0.86),无幽门螺杆菌感染风险亦低(HR 0.24;95%CI 0.09-0.60),而低血清高密度脂蛋白增加新发胃癌风险(HR 2.67;95%CI 1.14-6.16)。
要点
- 幽门螺杆菌成功根除组新发胃癌风险低于持续感染组(HR 0.29;95%CI 0.10-0.86)。
- 无幽门螺杆菌感染组新发胃癌风险亦低于持续感染组(HR 0.24;95%CI 0.09-0.60)。
- 低血清高密度脂蛋白增加新发胃癌风险(HR 2.67;95%CI 1.14-6.16)。
核心结论
- 幽门螺杆菌成功根除降低新发胃癌风险,而低高密度脂蛋白增加其风险。
研究设计与样本
- 大型回顾性队列研究,2003至2011年受试者接受内镜和幽门螺杆菌检测,随访内镜和幽门螺杆菌检测至2013年。
- 幽门螺杆菌感染采用快速尿素酶试验或组织学试验检测。
- 共纳入10328名健康受试者(5951名男性;平均年龄48.7岁),中位随访5.5年期间检出31例胃癌。
主要发现
- 非根除组3508名受试者中新发胃癌21例(0.6%),成功根除组2050名受试者中4例(0.2%),无幽门螺杆菌组4770名参与者中6例(0.13%)。
- 调整分析中,与持续感染组相比,幽门螺杆菌根除降低新发胃癌风险(HR 0.29;95%CI 0.10-0.86)。
- 无幽门螺杆菌感染组新发胃癌风险亦低于持续感染组(HR 0.24;95%CI 0.09-0.60)。
- 低血清高密度脂蛋白增加新发胃癌风险(HR 2.67;95%CI 1.14-6.16)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The effect of Helicobacter pylori eradication on de novo gastric cancer is controversial, although meta-analyses suggest a reduction in gastric cancer after eradication. The effect of high-density lipoprotein (HDL) on gastric cancer has been rarely reported. METHODS: In this large retrospective cohort study, participants underwent endoscopy and H pylori testing from 2003 to 2011 and underwent follow-up endoscopy and H pylori testing until 2013. H pylori infection was detected using a rapid urease test or histologic test. The H pylori eradication group was defined as successful eradication, whereas the H pylori persistent group was defined as noneradication or eradication failure. The risk of cancer was measured with hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: Among 10,328 healthy subjects (5951 men; mean age, 48.7 years), 31 gastric cancers were detected during a median follow-up of 5.5 years. De novo gastric cancer developed in 21 of 3508 subjects (.6%) in the noneradication group, 4 of 2050 subjects (.2%) in the successful eradication group, and 6 of 4770 participants (.13%) in the absence of H pylori group. In the adjusted analysis, H pylori eradication decreased de novo gastric cancer risk (HR, .29; 95% CI, .10-.86) compared with the persistent group. The risk of de novo gastric cancer in absence of H pylori was also much lower compared with the persistent group (HR, .24; 95% CI, .09-.60). Low serum HDL increased the risk of de novo gastric cancer (HR, 2.67; 95% CI, 1.14-6.16). CONCLUSIONS: Successful H pylori eradication reduced de novo gastric cancer, whereas low HDL increased its risk.
引用
- Nam SY, Park BJ, Nam JH, et al. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development. Gastrointest Endosc. 2019. PMID: 31034810. doi:10.1016/j.gie.2019.04.232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。